Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children

Summary

The goal of this observational study is to investigate the incidence, current management practices, and outcomes in pediatric patients with HAC after liver transplantation.

Research question:

* What are the overall incidence of HAC and the effectiveness of all treatment strategies for HAC after pediatric LT?
* What are the current management practices in the experience of centers, anticoagulant therapy, screening protocol, and assessment criteria for HAC after pediatric LT?

The burden of participation is considered to be minimal, and limited to the questionnaires.

Conditions

• Hepatic Artery Thrombosis
• Hepatic Artery Stenosis
• Pediatric ALL
• Liver Transplant; Complications

Sponsors & Collaborators

• J. P. Garrahan Hospital

  collaborator UNKNOWN

• Hospital Italiano de Buenos Aires

  collaborator OTHER

• Royal Children's Hospital

  collaborator OTHER

• Medical University of Innsbruck

  collaborator UNKNOWN

• Hospital Sírio-Libanês

  collaborator UNKNOWN

• Hospital Santo Antonio

  collaborator UNKNOWN

• Faculty of Medicine & Dentistry, University of Alberta

  collaborator UNKNOWN

• Zhejiang University

  collaborator OTHER

• Thomayer University Hospital

  collaborator OTHER

• Hôpital Bicêtre

  collaborator UNKNOWN

• University Children's Hospital

  collaborator OTHER

• Hannover Medical School

  collaborator OTHER

• Universitätsklinikum Hamburg-Eppendorf

  collaborator OTHER

• Dr Rela Institute and Medical Centre

  collaborator UNKNOWN

• Amrita Institute of Medical Sciences & Research Centre

  collaborator UNKNOWN

• Max Super Speciality Hospital

  collaborator OTHER

• Aster CMI Hospital

  collaborator UNKNOWN

• ASST Papa Giovanni XXIII Hospital

  collaborator UNKNOWN

• Bambino Gesù Children's Hospital

  collaborator UNKNOWN

• National Centre for Child Health and Development

  collaborator UNKNOWN

• Auckland City Hospital

  collaborator OTHER_GOV

• Children's Memorial Health Institute

  collaborator UNKNOWN

• King Faisal Specialist Hospital & Research Center

  collaborator OTHER

• National University Hospital, Singapore

  collaborator OTHER

• Wits Donald Gordon Medical Centre

  collaborator UNKNOWN

• La Paz University Hospital

  collaborator UNKNOWN

• Vall d'Hebron Barcelona Hospital Campus

  collaborator UNKNOWN

• Karolinska Institutet

  collaborator OTHER

• University Hospital, Geneva

  collaborator OTHER

• Birmingham Women's and Children's Hospital

  collaborator UNKNOWN

• Primary Children's Hospital

  collaborator OTHER

• Children's Hospital of Philadelphia

  collaborator OTHER

• Children's Hospital Pittsburgh

  collaborator UNKNOWN

• Recanati-Miller Transplantation Institute, Mount Sinai Hospital

  collaborator UNKNOWN

• Ann and Robert H. Lurie Children's Hospital of Chicago

  collaborator UNKNOWN

• University Medical Center Groningen

  lead OTHER

Eligibility

Min Age

0 Years

Max Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-09-28

Primary Completion

2025-12-31

Completion

2025-12-31

Countries

• Netherlands

Study Locations